|
Miltenyi Biotec
anti cd36 antibody Anti Cd36 Antibody, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+cd36/CD36+Antibody%2C+anti-human/pm36522122-44-38-56 Average 94 stars, based on 1 article reviews
anti cd36 antibody - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
MedChemExpress
compounds recombinant cd36 protein Compounds Recombinant Cd36 Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+cd36/CD36%2C+Human/pm40770043-59-6-13 Average 93 stars, based on 1 article reviews
compounds recombinant cd36 protein - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
cd36 pevio770 ![]() Cd36 Pevio770, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+cd36/CD36+Antibody%2C+anti-human%2C+REAfinity/pmc08070390-28-0-2 Average 94 stars, based on 1 article reviews
cd36 pevio770 - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
R&D Systems
anti human cd36 ![]() Anti Human Cd36, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+cd36/Human+CD36%2FSR-B3+Antibody/pm37604832-271-59-64 Average 90 stars, based on 1 article reviews
anti human cd36 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
OriGene
control shrna constructs ![]() Control Shrna Constructs, supplied by OriGene, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+cd36/CD36+Human+shRNA+Plasmid+Kit/bio_rxiv__2023__01__28__526013-45-3-6 Average 92 stars, based on 1 article reviews
control shrna constructs - by Bioz Stars,
2026-11
92/100 stars
|
Buy from Supplier |
|
R&D Systems
cd36 ![]() Cd36, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+cd36/Human+CD36%2FSR-B3+Antibody/pmc13091052-54-88-91 Average 94 stars, based on 1 article reviews
cd36 - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
R&D Systems
recombinant human cd36 ![]() Recombinant Human Cd36, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+cd36/Recombinant+Human+CD36+GST+(N-Term)+Protein/pmc04672576-111-24-27 Average 91 stars, based on 1 article reviews
recombinant human cd36 - by Bioz Stars,
2026-11
91/100 stars
|
Buy from Supplier |
|
fluidigm
3152007b ![]() 3152007b, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+cd36/Anti-Human+CD36+(5-271)-152Sm/pm31935371-235-231-229 Average 93 stars, based on 1 article reviews
3152007b - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
R&D Systems
anti cd36 ![]() Anti Cd36, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+cd36/Human+CD36%2FSR-B3+Alexa+Fluor%C2%AE+488-conjugated+Antibody/bio_rxiv__64898__2026__02__01__703119-97-13-17 Average 94 stars, based on 1 article reviews
anti cd36 - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
OriGene
sr319610 ![]() Sr319610, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+cd36/CD36+Human+siRNA+Oligo+Duplex/pmc06938262-51-9-6 Average 93 stars, based on 1 article reviews
sr319610 - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
OriGene
tl314090 ![]() Tl314090, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+cd36/CD36+Human+shRNA+Plasmid+Kit/pmc10432206-69-8-5 Average 93 stars, based on 1 article reviews
tl314090 - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Cancers
Article Title: Murlentamab, a Low Fucosylated Anti-Müllerian Hormone Type II Receptor (AMHRII) Antibody, Exhibits Anti-Tumor Activity through Tumor-Associated Macrophage Reprogrammation and T Cell Activation
doi: 10.3390/cancers13081845
Figure Lengend Snippet: Flow cytometry antibodies used.
Article Snippet:
Techniques: Flow Cytometry, In Vivo, In Vitro
Journal: Cancers
Article Title: Murlentamab, a Low Fucosylated Anti-Müllerian Hormone Type II Receptor (AMHRII) Antibody, Exhibits Anti-Tumor Activity through Tumor-Associated Macrophage Reprogrammation and T Cell Activation
doi: 10.3390/cancers13081845
Figure Lengend Snippet: Murlentamab opsonization of SKOV3-R2 + orients naïve macrophages and reprograms TAMs towards an M1-like profile. SKOV3-R2 + ovarian tumor cells were labeled with different 3C23K antibodies (3C23K-FcKO control, 3C23K-CHO normally fucosylated or murlentamab the low fucosylated form) and cultured in the presence of human monocyte-derived macrophages from healthy donors unstimulated (M0) or stimulated with M-CSF and IL-10 (TAMs). ( A ) The proportion of macrophages expressing M1/M2 membrane markers (CD32, CD64, CD80, TLR2, CD163, CD36 and CD206) was determined by flow cytometry after three days of co-culture with SKOV3-R2 + cells. ( B ) The release of cytokines (IL1β, IL12, TNFα, IL6, IFNγ, IL10) and chemokines (CCL2, CCL4, CCL5, CXCL9 and CXCL10) in the culture medium was determined by AlphaLISA after three days of co-culture with SKOV3-R2 + cells. Data shown (boxplots) are the results from three different experiments (performed with three different healthy donors). * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. p values were determined using one-way ANOVA analysis followed by Tukey’s multiple comparisons test.
Article Snippet:
Techniques: Labeling, Cell Culture, Derivative Assay, Expressing, Membrane, Flow Cytometry, Co-Culture Assay
Journal: Nature communications
Article Title: CD36 mediates SARS-CoV-2-envelope-protein-induced platelet activation and thrombosis.
doi: 10.1038/s41467-023-40824-7
Figure Lengend Snippet: Fig. 6 | CD36 deficiency or CD36 blockade in vivo attenuates E protein- enhanced thrombosis. a Levels of CD36 in wild-type (WT) and CD36−/−mouse platelets. Results were confirmed in three independent experiments using platelets from different mice. b and c WT and CD36−/−mice were intravenously injected with the E protein (4 μg per mouse) or PBS 4 h before the pulmonary embolism (PE) model. b Quantification of the numbers of lung embolisms per visual field on lung sections. Data are mean ± SD of 25 counts from 5 mice in each group. c Representative field on lung sections by hematoxylin-eosin (HE) staining from WT and CD36−/−mice injected with the E protein or PBS. Scale bar = 100 μm. d and e Inferior vena cava (IVC) stenosis model was performed in WT and CD36−/−mice. WT and CD36−/−mice were pretreated with the E protein (4 μg per mouse) or PBS. d Representative image of the IVC thrombi. e The quantification analysis of the thrombi weight (n = 5). f and g WT mice were intraperitoneally injected with 10 mg/ kg SB203580 or DMSO. After 2 h, mice were intravenously infused with the E
Article Snippet: Anti-phospho-p38 (1:1000, clone D3F9, #4511, CST), anti-p38 (1:1000, clone D13E1, #8690, CST), antiphospho-NF-κB p65 (1:1000, clone 93H1, #3033, CST), anti-NF-κB p65 (1:1000, clone D14E12, #8242, CST), anti-phospho-ERK (1:1000, clone D13.14.4E, #4370, CST), anti-ERK (1:1000, clone 137F5, #4695, CST), anti-phospho-JNK (1:1000, clone 81E11, #4668, CST), anti-JNK (1:1000, clone 56G8, #9258, CST), anti-ICAM-1 (1:1000, #4915, CST), anti-VCAM-1(1:1000, clone E1E8X, #13662, CST),
Techniques: In Vivo, Injection, Staining
Journal: Journal of Lipid Research
Article Title: Aerobic glycolysis drives differentiation of unilocular adipocytes
doi: 10.1016/j.jlr.2026.101023
Figure Lengend Snippet: HUVAS adipocytes are characterized by AMPK activation and high fatty acid uptake. A, B: Capillary Western blot analysis of p-AMPK T172 , total AMPK, p-HSL S660 , p-HSL S563 (shown with 2 contrasts), total HSL, and CD36 as well as quantification of the p-AMPK/AMPK and p-HSL/HSL ratios after normalization to total protein levels (Fig. S6A, S7A) across HUVAS, 2D, and 3D cultures from 3 technical replicates of the same individual on d30. C, D, isoprenaline-induced (C, shown as induced/basal) and basal (D) lipolysis measured by glycerol release across cultures from 8 technical replicates of the same individual. Similar results were obtained from cells from >three different cell donors. E, F: Quantification of the uptake of a BODIPY-labelled long-chain fatty acid tracer (BODIPY-FA) across HUVAS, 3D, and 2D cultures (E), and in HUVAS and 3D cultures in the absence or presence of the CD36 inhibitor SMS121 or vehicle (F). N ≥ 5 throughout; values in (F) are expressed as relative to the mean of HUVAS control to combine data from several experiments and cell donors. G–H: Quantification of CD36 mRNA expression expressed as normalized counts (G) and protein from capillary Western blot analysis (H) after normalization to total protein levels ( A) from 3 technical replicates of the same individual on d30. I–K: Effects of chronic treatment of HUVAS with CD36 inhibitor SMS121 d20-d30 shown as representative confocal images at d30 (I), adipocyte lipid droplet diameter (J), and unilocularity (K). n = 40 cells per spheroid and 2 spheroids per individual. Scale bars: 50 μm.
Article Snippet: Immunoblotting was performed using the following primary antibodies against: PLIN1 (1:10, PA5-81240, Fisher Scientific), CIDEC (1:10, PA1-46128, Invitrogen), UCP1 (1:50, MAB6158, R&D Systems), PPARγ (1:50, 2435S, Cell Signaling), FAS (1:50, 3180, BioTechne), ATGL (1:50, 2138, Cell Signaling), Total OXPHOS cocktail (1:50, Ab110411 , Abcam), TOMM20 (1:50, NBP1-81556, BioTechne), PTP1B (1:50, Ab244207 , Abcam), HIF1α (1:100, NBP2-75977, Novus), P-AMPK (Thr172, 1:10, 2535, Cell Signaling), total AMPK (1:50, 2532, Cell Signaling), P-HSL (Ser660, 1:10, 45,804, Cell Signaling), P-HSL (Ser563, 1:10, 4139, Cell Signaling), total HSL (1:50, 4107, Cell Signaling), and
Techniques: Activation Assay, Western Blot, Control, Expressing
Journal: bioRxiv
Article Title: Direct interactions of CEACAM1 and CD36 with LPS and each other
doi: 10.64898/2026.02.01.703119
Figure Lengend Snippet: A-C. Flow analysis of CEACAM1-4L and CD36-BioID2 expression in transfected HEK cells. ( A ) HEK cells untransfected controls. ( B ) HEK cells transfected with CD36-BioID2 only. ( C HEK cells transfected with both CD36-BioID2 and CEACAM1-4L. D-E . Immunoblots of HEK cells expressing only CD36-BioID2 (lane 1) or both CD36-BioID2 and CEACAM1-4L (lane 2), immunostained with antibodies to CD36 ( D ) or CEACAM1-4L ( E ). Transfected cells were grown for 4 days, incubated with 50 µM biotin overnight, washed twice with PBS, lysed with 1% NP40, incubated with streptavidin beads for 4 hrs, eluted with SDS running buffer, run on SDS gels and immunoblotted with either anti-CD36 or anti-CEACAM1 antibodies.
Article Snippet: On day 4 following transfection, the cells were collected and stained with either
Techniques: Expressing, Transfection, Western Blot, Incubation
Journal: Cell reports
Article Title: CD36-Mediated Metabolic Rewiring of Breast Cancer Cells Promotes Resistance to HER2-Targeted Therapies
doi: 10.1016/j.celrep.2019.11.008
Figure Lengend Snippet:
Article Snippet: CD36 Human siRNA Oligo Duplex ,
Techniques: Blocking Assay, Control, Recombinant, Isolation, cDNA Synthesis, SYBR Green Assay, Transfection, Proliferation Assay, Microarray, Negative Control, Software
Journal: iScience
Article Title: Targeting CD36 determines nicotine derivative NNK-induced lung adenocarcinoma carcinogenesis
doi: 10.1016/j.isci.2023.107477
Figure Lengend Snippet:
Article Snippet: CD36 shRNA: 5'-GGACCATTGGTGATGAGAAGG CAAACATG-3' ,
Techniques: Recombinant, Virus, Subcloning, Plasmid Preparation, shRNA, Software